NCT07038369 2026-03-17A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsAtavistik Bio, IncPhase 1 Active not recruiting134 enrolled
NCT06257264 2026-03-05A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage TumorsBeOne MedicinesPhase 1 Recruiting258 enrolled
NCT07288359 2026-02-23Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid TumorsNovartisPhase 1/2 Recruiting205 enrolled
NCT03197571 2025-02-21QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyImmunityBio, Inc.Phase 1/2 Withdrawn